Pembrolizumab
-
{
- All
- News
-
What Is Keytruda And Why Is Everyone Talking About It In India's Cancer Fight?
In India, Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
What Is Keytruda And Why Is Everyone Talking About It In India's Cancer Fight?
In India, Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
New Hope For Bowel Cancer: Immunotherapy Drug Offers Cure Without Surgery
A groundbreaking immunotherapy drug, Pembrolizumab (Keytruda), shows promising results in treating bowel cancer by targeting specific immune cell proteins.
-
What Is Keytruda And Why Is Everyone Talking About It In India's Cancer Fight?
In India, Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
What Is Keytruda And Why Is Everyone Talking About It In India's Cancer Fight?
In India, Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
New Hope For Bowel Cancer: Immunotherapy Drug Offers Cure Without Surgery
A groundbreaking immunotherapy drug, Pembrolizumab (Keytruda), shows promising results in treating bowel cancer by targeting specific immune cell proteins.
